Contact

Steady Lantern 83 Home About Services Research Trials Travel & Clinics Policy & Access Contact US access signal / 2026 Ibogaine Treatment In The Us: What Exists Today The practical picture remains narrow: investigational research pathways, legal limits under federal law, and offshore choices that carry meaningful safety and access questions. Schedule I status clinical trials risk clarity 01 / current reality Understanding ibogaine Ibogaine is a psychoactive indole alkaloid derived from the iboga plant , Tabernanthe iboga , native to Central West Africa. Its traditional use includes spiritual and medicinal practices, while modern interest centers on drug addiction, opioid withdrawal, and possible changes in craving. Known for dissociative and hallucinogenic properties, ibogaine can produce a prolonged waking-dream state that may last 24 to 48 hours. That intensity is one reason it is not comparable to ordinary outpatient addiction treatment or to non-addictive substances used in standard care. People often encounter broad claims about therapeutic potential when searching for ibogaine therapy benefits . The more useful distinction is between a reported psychospiritual experience and established clinical evidence: personal accounts can be meaningful, but they do not settle safety or effectiveness. There is no ordinary legal clinical access to ibogaine in the United States today. The available paths are authorized research or treatment outside US federal jurisdiction. This resource is independent and evidence-first. Our approach to explaining uncertainty and access realities is designed to help people distinguish investigational pathways from unapproved offerings without presenting them as equivalent. Signal check: origin, mechanism, screening, and evidence are separate questions. 02 / regulation The legal status of ibogaine in the US Legal language matters because state discussion does not override federal restrictions on a Schedule I controlled substance. A /

Contact

Reach us through published channels